Rachel King

Rachel King is a highly accomplished professional with a strong background in the biotechnology and pharmaceutical industry.

She holds an AB from Dartmouth College and pursued further studies at Harvard Business School, showcasing a commitment to academic excellence.

Rachel has held key positions in various organizations, including serving as a Member of the Board of Directors at Novavax and previously at Biotechnology Innovation Organization and GlycoMimetics.

Her leadership roles extend to being the Former Chair of the Board of Directors at Biotechnology Innovation Organization, Co-Founder, and CEO at GlycoMimetics, and Senior Vice President at Novartis Corporation.

With extensive experience, Rachel has also excelled as the Former CEO of Genetic Therapy, Inc, Vice President of Product Planning at Genetic Therapy, and as an Associate at Bain and Company.

Her contributions to the industry further include a role as an Entrepreneur in Residence at New Enterprise Associates, highlighting her innovative and entrepreneurial spirit.

Rachel King's diverse background and strategic insights make her a valuable asset to the organizations she has been a part of.